Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00526136
Status:
COMPLETED
Last Update Posted:
2008-12-18
First Post:
2007-09-05
Brief Title:
Vernakalant Oral Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
Sponsor:
Advanz Pharma
Organization:
Advanz Pharma
Organization Data
Organization:
Advanz Pharma
Class:
INDUSTRY
Study ID:
1235-SR-202-AF
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Advanz Pharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Gregory Beatch PhD Vice President Scientific Affairs
Old Organization:
Cardiome Pharma Corp